Successful use of one dose of recombinant factor VIIa to control severe bleeding after emergency aortic arch replacement in deep hypothermic circulatory arrest

Journal of Thoracic and Cardiovascular Surgery

Volumn 128, Issue 6, 2004, Pages 941-943

  Wiesenack, Christoph ^a   Arlt, Matthias ^a   Liebold, Andreas ^a   Schmid, Franz X ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DESMOPRESSIN; FRESH FROZEN PLASMA; HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ANGIOCARDIOGRAPHY; AORTA DISSECTION; AORTA SURGERY; ARTICLE; BLEEDING; BLOOD CLOTTING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ERYTHROCYTE; EXTRACORPOREAL CIRCULATION; HEMODYNAMIC MONITORING; HUMAN; INDUCED HYPOTHERMIA; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION;

ANEURYSM, DISSECTING; AORTIC ANEURYSM; BLOOD LOSS, SURGICAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; EMERGENCY MEDICAL SERVICES; FACTOR VIII; HEART ARREST, INDUCED; HUMANS; HYPOTHERMIA, INDUCED; MALE; MIDDLE AGED;

EID: 9644291364     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.03.018     Document Type: Article

References (6)

1. Green J.A., Spiess B.D. Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest. Anesthesiol Clin North Am. 21:2003;527-551
2. Stratmann G., Russell I.A., Merrick S.H. Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair. Ann Thorac Surg. 76:2003;2094-2097
3. Kouchoukos N.T., Marshall W.G. Jr, Wedige-Stecher T.A. Eleven-year experience with composite graft replacement of the ascending aorta and aortic valve. J Thorac Cardiovasc Surg. 92:1986;691-705
4. Mora Mangano C.T., Neville M.J., Hsu P.H., Mignea I., King J., Miller D.C. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation. 104:(suppl 1):2001;I276-281
5. Meng Z.H., Wolberg A.S., Monroe D.M. III, Hoffman M. The effect of temperature and pH on the activity of factor VIIa implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma. 55:2003;886-891
6. Bui J.D., Despotis G.D., Trulock E.P., Patterson G.A., Goodnough L.T. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg. 124:2002;852-854